Literature DB >> 27021937

Mechanisms of Lung Fibrosis Resolution.

Stephan W Glasser1, James S Hagood2, Simon Wong3, Carmen A Taype4, Satish K Madala5, William D Hardie6.   

Abstract

Fibrogenesis involves a dynamic interplay between factors that promote the biosynthesis and deposition of extracellular matrix along with pathways that degrade the extracellular matrix and eliminate the primary effector cells. Opposing the often held perception that fibrotic tissue is permanent, animal studies and clinical data now demonstrate the highly plastic nature of organ fibrosis that can, under certain circumstances, regress. This review describes the current understanding of the mechanisms whereby the lung is known to resolve fibrosis focusing on degradation of the extracellular matrix, removal of myofibroblasts, and the role of inflammatory cells. Although there are significant gaps in understanding lung fibrosis resolution, accelerated improvements in biotechnology and bioinformatics are expected to improve the understanding of these mechanisms and have high potential to lead to novel and effective restorative therapies in the treatment not only of pulmonary fibrosis, but also of a wide-ranging spectrum of chronic disorders.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27021937      PMCID: PMC4861766          DOI: 10.1016/j.ajpath.2016.01.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  98 in total

1.  Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.

Authors:  Jeffrey C Horowitz; Iyabode O Ajayi; Priya Kulasekaran; David S Rogers; Joshua B White; Sarah K Townsend; Eric S White; Richard S Nho; Peter D R Higgins; Steven K Huang; Thomas H Sisson
Journal:  Int J Biochem Cell Biol       Date:  2011-10-25       Impact factor: 5.085

2.  Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.

Authors:  Yong Zhou; Xiangwei Huang; Louise Hecker; Deepali Kurundkar; Ashish Kurundkar; Hui Liu; Tong-Huan Jin; Leena Desai; Karen Bernard; Victor J Thannickal
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

3.  Reversibility of liver fibrosis.

Authors:  David A Brenner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

4.  Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.

Authors:  Yan Y Sanders; James S Hagood; Hui Liu; Wei Zhang; Namasivayam Ambalavanan; Victor J Thannickal
Journal:  Eur Respir J       Date:  2014-03-06       Impact factor: 16.671

5.  Collagen and elastin fibers in human pulmonary alveolar walls.

Authors:  S S Sobin; Y C Fung; H M Tremer
Journal:  J Appl Physiol (1985)       Date:  1988-04

6.  Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.

Authors:  Priya Kulasekaran; Casey A Scavone; David S Rogers; Douglas A Arenberg; Victor J Thannickal; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

Review 7.  Functions and mechanisms of action of CCN matricellular proteins.

Authors:  Chih-Chiun Chen; Lester F Lau
Journal:  Int J Biochem Cell Biol       Date:  2008-08-15       Impact factor: 5.085

Review 8.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

9.  Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10.

Authors:  Eric S White; Victor J Thannickal; Shannon L Carskadon; Emily G Dickie; Donna L Livant; Sonja Markwart; Galen B Toews; Douglas A Arenberg
Journal:  Am J Respir Crit Care Med       Date:  2003-06-05       Impact factor: 21.405

10.  Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Jonas Christian Schupp; Harald Binder; Benedikt Jäger; Giuseppe Cillis; Gernot Zissel; Joachim Müller-Quernheim; Antje Prasse
Journal:  PLoS One       Date:  2015-01-15       Impact factor: 3.240

View more
  49 in total

Review 1.  In Vitro Models to Study Human Lung Development, Disease and Homeostasis.

Authors:  Alyssa J Miller; Jason R Spence
Journal:  Physiology (Bethesda)       Date:  2017-05

2.  Hsp90 regulation of fibroblast activation in pulmonary fibrosis.

Authors:  Vishwaraj Sontake; Yunguan Wang; Rajesh K Kasam; Debora Sinner; Geereddy B Reddy; Anjaparavanda P Naren; Francis X McCormack; Eric S White; Anil G Jegga; Satish K Madala
Journal:  JCI Insight       Date:  2017-02-23

3.  Releasing Tensin.

Authors:  Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2017-04       Impact factor: 6.914

Review 4.  New therapeutics based on emerging concepts in pulmonary fibrosis.

Authors:  Vishwaraj Sontake; Prathibha R Gajjala; Rajesh K Kasam; Satish K Madala
Journal:  Expert Opin Ther Targets       Date:  2018-11-28       Impact factor: 6.902

5.  Urokinase Plasminogen Activator Overexpression Reverses Established Lung Fibrosis.

Authors:  Jeffrey C Horowitz; Daniel J Tschumperlin; Kevin K Kim; John J Osterholzer; Natalya Subbotina; Iyabode O Ajayi; Seagal Teitz-Tennenbaum; Ammara Virk; Megan Dotson; Fei Liu; Delphine Sicard; Shijing Jia; Thomas H Sisson
Journal:  Thromb Haemost       Date:  2019-11-08       Impact factor: 5.249

6.  Serelaxin enhances the therapeutic effects of human amnion epithelial cell-derived exosomes in experimental models of lung disease.

Authors:  Simon G Royce; Krupesh P Patel; WeiYi Mao; Dandan Zhu; Rebecca Lim; Chrishan S Samuel
Journal:  Br J Pharmacol       Date:  2019-05-07       Impact factor: 8.739

Review 7.  Matrix biomechanics and dynamics in pulmonary fibrosis.

Authors:  Andrew J Haak; Qi Tan; Daniel J Tschumperlin
Journal:  Matrix Biol       Date:  2017-12-21       Impact factor: 11.583

8.  Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution.

Authors:  Huachun Cui; Dingyuan Jiang; Sami Banerjee; Na Xie; Tejaswini Kulkarni; Rui-Ming Liu; Steven R Duncan; Gang Liu
Journal:  JCI Insight       Date:  2020-03-12

Review 9.  You Say You Want a Resolution (of Fibrosis).

Authors:  Kamran Atabai; Christopher D Yang; Michael J Podolsky
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

Review 10.  The mesenchymal context in inflammation, immunity and cancer.

Authors:  Vasiliki Koliaraki; Alejandro Prados; Marietta Armaka; George Kollias
Journal:  Nat Immunol       Date:  2020-08-03       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.